Driving CDMO Efficiency: The Power Of Flexible Platforms And Digital Data Access

This webinar delves into KBI Biopharma’s adaptable and innovative platform technologies designed to revolutionize bioprocessing efficiency. We showcase how our mammalian (SUREtechnology Platform™, powered by Selexis®) and microbial (PUREplatform™) End-to-End Cell Line Development solutions, coupled with our industry-leading analytical capabilities, expedite the development, process characterization, and manufacturing of mAbs, multispecific Abs, ADCs, fusion proteins, and other recombinant therapeutic proteins.

Additionally, we spotlight PROGRAMview™, our cutting-edge digital collaboration platform, demonstrating its role in enhancing data accessibility and collaboration throughout process development. This groundbreaking platform accelerates informed decision-making, fosters transparency, and strengthens open communication between us and our partners, ultimately improving bioprocess speed and quality attributes. The webinar features case studies, a brief demonstration of PROGRAMview™, and a Q&A session with our experts.

Key Outcomes

• Gain a comprehensive understanding of how KBI Biopharma’s SUREtechnology Platform™ and PUREplatform™ expression systems streamline the development and manufacturing of complex biotherapeutics, including mAbs, multispecific Abs, ADCs, and fusion proteins.
• Learn how KBI Biopharma’s advanced analytics optimize processes, refine product characterization, and more efficiently support regulatory requirements.
• Discover the features and advantages of PROGRAMview™, KBI Biopharma’s digital collaboration platform, designed to enhance transparency and communication during process development.